Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic.

Verster JC, Volkerts ER.

Ann Allergy Asthma Immunol. 2004 Mar;92(3):294-303; quiz 303-5, 355. Review. Erratum in: Ann Allergy Asthma Immunol. 2004 Jun;92(6):675. Ann Allergy Asthma Immunol. 2005 Mar;94(3):409-10.

PMID:
15049392
3.
4.

A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.

Theunissen EL, Vermeeren A, van Oers AC, van Maris I, Ramaekers JG.

Clin Exp Allergy. 2004 Feb;34(2):250-8.

PMID:
14987305
5.
6.

Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator.

Weiler JM, Bloomfield JR, Woodworth GG, Grant AR, Layton TA, Brown TL, McKenzie DR, Baker TW, Watson GS.

Ann Intern Med. 2000 Mar 7;132(5):354-63.

PMID:
10691585
7.

Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Theunissen EL, Vermeeren A, Ramaekers JG.

Br J Clin Pharmacol. 2006 Jan;61(1):79-86.

8.

Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial.

Verster JC, de Weert AM, Bijtjes SI, Aarab M, van Oosterwijck AW, Eijken EJ, Verbaten MN, Volkerts ER.

Psychopharmacology (Berl). 2003 Aug;169(1):84-90. Epub 2003 Apr 30.

PMID:
12721777
10.
11.

Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis.

Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV.

J Allergy Clin Immunol. 2003 Apr;111(4):770-6.

PMID:
12704356
12.

Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood.

Verster JC, Volkerts ER, van Oosterwijck AW, Aarab M, Bijtjes SI, De Weert AM, Eijken EJ, Verbaten MN.

J Allergy Clin Immunol. 2003 Mar;111(3):623-7.

PMID:
12642847
13.

Second-generation antihistamines for the treatment of chronic idiopathic urticaria.

Belsito DV.

J Drugs Dermatol. 2010 May;9(5):503-12. Review.

PMID:
20480793
14.

Safety of antihistamines in children.

Ten Eick AP, Blumer JL, Reed MD.

Drug Saf. 2001;24(2):119-47. Review.

PMID:
11235817
15.

Variations among non-sedating antihistamines: are there real differences?

Mattila MJ, Paakkari I.

Eur J Clin Pharmacol. 1999 Apr;55(2):85-93. Review.

PMID:
10335901
16.

A review of the effects of antihistamines on mental processes related to automobile driving.

Gengo FM, Manning C.

J Allergy Clin Immunol. 1990 Dec;86(6 Pt 2):1034-9. Review.

PMID:
1979799
17.

Pharmacokinetic overview of oral second-generation H1 antihistamines.

González MA, Estes KS.

Int J Clin Pharmacol Ther. 1998 May;36(5):292-300. Review.

PMID:
9629995
18.

Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies.

Rosenzweig P, Patat A.

Clin Exp Allergy. 1999 Jul;29 Suppl 3:156-62.

PMID:
10444231
19.

Treatment of urticaria. An evidence-based evaluation of antihistamines.

Lee EE, Maibach HI.

Am J Clin Dermatol. 2001;2(1):27-32. Review.

PMID:
11702618

Supplemental Content

Support Center